Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Scientific Reports|May 27, 2021
A psychoacoustic test for misophonia assessmentFalco Enzler, Céline Loriot, Philippe Fournier, et al.Oncotarget|February 1, 2018
CKS protein overexpression renders tumors susceptible to a chemotherapeutic strategy that protects normal tissuesJohn Tat, Céline Loriot, Martha Henze, et al.The American Journal of Pathology|September 13, 2011
Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cellsValérie Gratio, Céline Loriot, G Duke Virca, et al.The Journal of Clinical Endocrinology and Metabolism|April 12, 2012
Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutationsCéline Loriot, Nelly Burnichon, Noémie Gadessaud, et al.Oncotarget|October 14, 2015
Deciphering the molecular basis of invasiveness in Sdhb-deficient cellsCéline Loriot, Mélanie Domingues, Adeline Berger, et al.Human Molecular Genetics|September 11, 2012
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytomaNelly Burnichon, Alexandre Buffet, Béatrice Parfait, et al.Cancer Cell|May 28, 2013
SDH mutations establish a hypermethylator phenotype in paragangliomaEric Letouzé, Cosimo Martinelli, Céline Loriot, et al.International Journal of Cancer|April 23, 2014
SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paragangliomaJulien Hadoux, Judith Favier, Jean-Yves Scoazec, et al.Nature Communications|January 28, 2015
Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomasLuis Jaime Castro-Vega, Eric Letouzé, Nelly Burnichon, et al.Pageof 1